Endo, Inc. financial data

Symbol
NDOI on OTC
Industry
Pharmaceutical Preparations
Location
1400 Atwater Drive, Malvern, PA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 5, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 76.4M shares
Common Stock, Shares, Outstanding 76.2M shares
Common Stock, Value, Issued 76K USD
Weighted Average Number of Shares Outstanding, Basic 76.2M shares
Weighted Average Number of Shares Outstanding, Diluted 76.2M shares

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 427M USD
Cost of Revenue 448M USD
Nonoperating Income (Expense) 1.19M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -256M USD
Income Tax Expense (Benefit) -22.8M USD
Net Income (Loss) Attributable to Parent -233M USD
Earnings Per Share, Basic -3.06 USD/shares
Earnings Per Share, Diluted -3.06 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 368M USD
Accounts Receivable, after Allowance for Credit Loss, Current 383M USD
Inventory, Net 613M USD
Assets, Current 1.53B USD
Deferred Income Tax Assets, Net 120M USD
Operating Lease, Right-of-Use Asset 27.2M USD
Intangible Assets, Net (Excluding Goodwill) 2.12B USD
Goodwill 0 USD
Other Assets, Noncurrent 337M USD
Assets 4.68B USD
Contract with Customer, Liability, Current 600K USD
Liabilities, Current 547M USD
Deferred Income Tax Liabilities, Net 5.66M USD
Operating Lease, Liability, Noncurrent 21.7M USD
Other Liabilities, Noncurrent 74.7M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax 551K USD
Retained Earnings (Accumulated Deficit) -382M USD
Stockholders' Equity Attributable to Parent 1.6B USD
Liabilities and Equity 4.68B USD

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 1B shares
Common Stock, Shares, Issued 76.2M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 455M USD
Operating Lease, Liability 27.5M USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -232M USD
Operating Lease, Liability, Current 5.87M USD
Additional Paid in Capital 1.98B USD
Amortization of Intangible Assets 61.4M USD